Prometheus Therapeutics Inc.

CIK 1823161 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Prometheus Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Apr 15, 2026D/A0001823161-26-000001
Jun 21, 2024D/A0001823161-24-000002
Apr 12, 2024D/A0001823161-24-000001
Feb 13, 2023D0001823161-23-000001
Jul 26, 2022D0001823161-22-000001
Sep 8, 2020D0001823161-20-000001